1938 related articles for article (PubMed ID: 25079328)
41. Metagenomics: key to human gut microbiota.
Maccaferri S; Biagi E; Brigidi P
Dig Dis; 2011; 29(6):525-30. PubMed ID: 22179207
[TBL] [Abstract][Full Text] [Related]
42. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis.
Lv LX; Fang DQ; Shi D; Chen DY; Yan R; Zhu YX; Chen YF; Shao L; Guo FF; Wu WR; Li A; Shi HY; Jiang XW; Jiang HY; Xiao YH; Zheng SS; Li LJ
Environ Microbiol; 2016 Jul; 18(7):2272-86. PubMed ID: 27243236
[TBL] [Abstract][Full Text] [Related]
43. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
[TBL] [Abstract][Full Text] [Related]
44. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
[TBL] [Abstract][Full Text] [Related]
45. Alterations of the Gut Microbiome in Hypertension.
Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
[No Abstract] [Full Text] [Related]
46. The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics.
Dubourg G; Lagier JC; Armougom F; Robert C; Hamad I; Brouqui P; Raoult D
Eur J Clin Microbiol Infect Dis; 2013 May; 32(5):637-45. PubMed ID: 23291779
[TBL] [Abstract][Full Text] [Related]
47. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
Ghosh TS; Das M; Jeffery IB; O'Toole PW
Elife; 2020 Mar; 9():. PubMed ID: 32159510
[TBL] [Abstract][Full Text] [Related]
48. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
49. The bacterial skin microbiome in psoriatic arthritis, an unexplored link in pathogenesis: challenges and opportunities offered by recent technological advances.
Castelino M; Eyre S; Upton M; Ho P; Barton A
Rheumatology (Oxford); 2014 May; 53(5):777-84. PubMed ID: 24067887
[TBL] [Abstract][Full Text] [Related]
50. Phylogeny, culturing, and metagenomics of the human gut microbiota.
Walker AW; Duncan SH; Louis P; Flint HJ
Trends Microbiol; 2014 May; 22(5):267-74. PubMed ID: 24698744
[TBL] [Abstract][Full Text] [Related]
51. Assessing the human gut microbiota in metabolic diseases.
Karlsson F; Tremaroli V; Nielsen J; Bäckhed F
Diabetes; 2013 Oct; 62(10):3341-9. PubMed ID: 24065795
[TBL] [Abstract][Full Text] [Related]
52. The association of type II diabetes with gut microbiota composition.
Navab-Moghadam F; Sedighi M; Khamseh ME; Alaei-Shahmiri F; Talebi M; Razavi S; Amirmozafari N
Microb Pathog; 2017 Sep; 110():630-636. PubMed ID: 28739439
[TBL] [Abstract][Full Text] [Related]
53. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study.
Wu T; Zhang Z; Liu B; Hou D; Liang Y; Zhang J; Shi P
BMC Genomics; 2013 Oct; 14():669. PubMed ID: 24083370
[TBL] [Abstract][Full Text] [Related]
54. Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration.
Sarangi AN; Goel A; Singh A; Sasi A; Aggarwal R
BMC Gastroenterol; 2017 Nov; 17(1):125. PubMed ID: 29179682
[TBL] [Abstract][Full Text] [Related]
55. Alterations of Bacteroides sp., Neisseria sp., Actinomyces sp., and Streptococcus sp. populations in the oropharyngeal microbiome are associated with liver cirrhosis and pneumonia.
Lu H; Qian G; Ren Z; Zhang C; Zhang H; Xu W; Ye P; Yang Y; Li L
BMC Infect Dis; 2015 Jun; 15():239. PubMed ID: 26099252
[TBL] [Abstract][Full Text] [Related]
56. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
57. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review.
Lucas López R; Grande Burgos MJ; Gálvez A; Pérez Pulido R
APMIS; 2017 Jan; 125(1):3-10. PubMed ID: 27704622
[TBL] [Abstract][Full Text] [Related]
58. Further analysis reveals new gut microbiome markers of type 2 diabetes mellitus.
Wang X; Xu X; Xia Y
Antonie Van Leeuwenhoek; 2017 Mar; 110(3):445-453. PubMed ID: 27943013
[TBL] [Abstract][Full Text] [Related]
59. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.
Loomba R; Seguritan V; Li W; Long T; Klitgord N; Bhatt A; Dulai PS; Caussy C; Bettencourt R; Highlander SK; Jones MB; Sirlin CB; Schnabl B; Brinkac L; Schork N; Chen CH; Brenner DA; Biggs W; Yooseph S; Venter JC; Nelson KE
Cell Metab; 2017 May; 25(5):1054-1062.e5. PubMed ID: 28467925
[TBL] [Abstract][Full Text] [Related]
60. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
